A novel operant testing regimen for multi-construct cognitive characterization of a murine model of Alzheimer's amyloid-related behavioral impairment

Neurobiology of Learning and Memory

Volumn 96, Issue 3, 2011, Pages 443-451

  Blackshear, Alice L ^a   Xu, Wenjin ^a   Anderson, Maria ^a   Xu, Feng ^b   Previti, Mary Lou ^b   Van Nostrand, William E ^b   Robinson, John K ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Learning; Memory; Operant; Tg2576; Transgenic

Indexed keywords

AMYLOID;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVERSION; BEHAVIOR; COGNITION; CONTROLLED STUDY; DEMENTIA; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INSTRUMENTAL CONDITIONING; MOTIVATION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; REACTION TIME; SIGNAL DETECTION;

ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANIMALS; ASSOCIATION LEARNING; BEHAVIOR, ANIMAL; COGNITION; CONDITIONING, OPERANT; DISCRIMINATION LEARNING; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MICE, TRANSGENIC; MOTIVATION;

EID: 80053615120     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2011.06.017     Document Type: Article

References (60)

1. Adriani W., Ognibene E., Heuland E., Ghirardi O., Caprioli A., Laviola G. Motor impulsivity in APP-SWE mice. A model of Alzheimer's disease. Behavioral Pharmacology 2006, 17:525-533.
2. Alzheimer A. Ueber eine eigenartige Erkrankung der Hirnrinde [On a peculiar disease of the cerebral cortex]. Zeitschrift fuer Psychiatrie 1907, 64:146.
3. Arendash G.W., King D.L. Intra- and inter-task relationships in a behavioral test battery given to Tg2576 transgenic mice and controls. Physiology & Behavior 2002, 75:643-652.
4. Arendash G.W., Lewis J., Leighty R.E., McGowan E., Cracchiolo J.R., Hutton M., et al. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: Linkage of poorer cognitive performance to tau pathology in forebrain. Brain Research 2004, 1012:29-41.
5. Ashe K.H. Learning and memory in transgenic mice modeling Alzheimer's disease. Learning & Memory 2001, 8:301-308.
6. Barnes P., Good M. Impaired Pavlovian cued fear conditioning in Tg2576 mice expressing a human mutant amyloid precursor protein gene. Behavioral Brain Research 2005, 157:107-117.
7. Barnes P., Hale G., Good M. Intramaze and extramaze cue processing in adult APPSWE Tg2576 transgenic mice. Behavioral Neuroscience 2004, 118:1184-1195.
8. Bartus R.T. On neurodegenerative diseases, models, and other treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Experimental Neurology 2000, 163:495-529.
9. Billings L.M., Oddo S., Green K.N., McGaugh J.L., LaFerla F.M. Intraneuronal AB causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005, 45:675-688.
10. Bizon J., Prescott S., Nicolle M.M. Intact spatial learning in adult Tg2576 mice. Neurobiology of Aging 2007, 28:440-446.
11. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nature Neuroscience 1999, 2:271-276.
12. Cohen J. The earth is round (p<.05). American Psychologist 1994, 47:997-1003.
13. Corcoran K.A., Lu Y., Turner R.S., Maren S. Overexpression of hAPPswe impair srewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease. Learning & Memory 2002, 9:243-252.
14. Davies P., Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976, 2:1403.
15. Deacon R.M., Koros E., Bornemann K.D., Rawlins J.N. Aged Tg2576 mice are impaired on social memory and open field habituation tests. Behavioral Brain Research 2009, 197:466-468.
16. DeMattos R.B., O'dell M.A., Parsadanian M., Taylor J.W., Harmony J.A., Bales K.R., et al. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proceedings of the National Academies of Science, USA 2002, 99:10843-10848.
17. Dickson T.C., Vickers J.C. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease. Neuroscience 2001, 105:99-107.
18. Dodart J.C., Bales K.R., Gannon K.S., Greene S.J., DeMattos R.B., Mathis C., et al. Immunization reverses memory deficits without reducing brain AB burden in Alzheimer's disease model. Nature Neuroscience 2002, 5:452-457.
19. Dunnett S.B., Evenden J.L., Iverson S.D. Delay-dependent short-term memory deficits in aged rats. Psychopharmacology 1988, 96:174-180.
20. Engel T., Hernandez F., Avila J., Lucas J.L. Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3. Neurobiology of Disease 2006, 26:5083-5090.
21. Eriksen J.L., Janus C.G. Plaques, tangles and memory loss in mouse models of neurodegeneration. Behavior Genetics 2007, 37:79-100.
22. Frautschy S.A., Yang F., Irrizary M., Hyman B., Saido T.C., Hsiao K., et al. Microgial response to amyloid plaques in APPswe transgenic mice. American Journal of Pathology 1998, 152:307-317.
23. Good M.A., Hale G. The " Swedish" mutation of the amyloid precursor protein (APPswe) dissociates components of object-location memory in aged Tg2576 mice. Behavioral Neuroscience 2007, 121:1180-1191.
24. Götz J., Deters N., Doldissen A., Bokhari L., Ke Y., Wiesner A., et al. A decade of tau transgenic animals and beyond. International Society of Neuropathology 2007, 17:91-103.
25. Hale G., Good M. Impaired visuospatial recognition memory but normal object novelty detection and relative familiarity judgments in adult mice expressing the APPswe Alzheimer's disease mutation. Behavioral Neuroscience 2005, 119:884-891.
26. Heyser C.J., Hampson R.E., Deadwyler S.A. Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: Alterations in short-term memory associated with changes in task-specific firing of hippocampal cells. Journal of Pharmacology and Experimental Therapeutics 1993, 264:294-307.
27. Hodos W., Kalman G. Effects of increment size and reinforce volume on progressive ratio performance. Journal of Experimental Analysis of Behavior 1963, 6:387-392.
28. Holcomb L.A., Gordon M.N., Jantzen P., Hsiao K., Duff K., Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and Presenilin-1 mutations: Lack of association with amyloid deposits. Behavior Genetics 1999, 29:177-185.
29. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits Aβ elevation and amyloid plaques in transgenic mice. Science 1996, 274:99-102.
30. Iqbal K., Alonso Adel C., Chen S., Chohan M.O., El-Akkad E., Gong C.X., et al. Tau pathology in Alzheimer's disease and other tauopathies. Biochimica et Biophysica Acta 2005, 1739:198-210.
31. Jensen L.H., Stephens D.N., Sarter M., Petersen E.N. Bidirectional effects of beta-carbolines and benzodiazepines on cognitive processes. Brain Research Bulletin 1987, 19:359-364.
32. King D.L., Arendash G.W. Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19months. Physiology & Behavior 2002, 75:627-642.
33. King D.L., Arendash G.W. Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: Correlations with cognitive impairment. Brain Research 2002, 926:58-68.
34. King D.L., Arendash G.W., Crawford F., Sterk T., Menendez J., Mullan M.J. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behavioral Brain Research 1999, 103:145-162.
35. Kokjohn T.A., Roher A.E. Amyloid precursor protein transgenic mouse models and Alzhiemer's disease: Understanding the paradigms, limitations and contributions. Alzheimer's & Dementia 2009, 5:340-347.
36. Kritzer M.F., Brewer A., Montalmont F., Davenport M., Robinson J.K. Effects of gonadectomy on performance of operant tasks measuring prefrontal cortical function in adult male rats. Hormones & Behavior 2007, 51:183-194.
37. Lagadec, S., Rotureau, L., Hémar, A., Macrez, N., Delcasso, S., Jeantet, Y. & Cho, Y. H. (2010). Early temporal short-term memory deficits in double transgenic APP/PS1 mice. Neurobiology of Aging (2010 September 1, Epub. ahead of print).
38. Middei S., Daniele S., Caprioli A., Ghirardi O., Ammassari-Teule M. Progressive cognitive decline in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe. Genes, Brain & Behavior 2006, 5:249-256.
39. Montgomery K.S., Simmons R.K., Edwards G., Nicolle M.M., Gluck M.A., Myers C.E., et al. Novel age-dependent learning deficits in a mouse model of Alzheimer's disease: Implications for translational research. Neurobiology of Aging 2009, 32:1273-1285.
40. Murrell J., Farlow M., Ghetti B., Benson M.D. A mutation in the amyloid precursor protein associated with heredity Alzheimer's disease. Science 1991, 254:97-99.
41. Ognibene E., Middei S., Daniele S., Adriani W., Ghirardi O., Caprioli A., et al. Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease. Behavioral Brain Research 2005, 156:225-232.
42. Ohno M., Chang L., Tseng W., Oakley H., Citron M., Klein W.L., et al. Temporal memory deficits in Alzheimer's mouse models: Rescue by geneticdeletion of BACE1. European Journal of Neuroscience 2006, 23:251-260.
43. Price D.L., Walker L.C., Martin L.J., Sisodie S.S. Amyloidosis in aging and Alzheimer's disease. American Journal of Pathology 1992, 141:767-772.
44. Quinn J.F., Bussiere J.R., Hammond R.S., Montine T.J., Henson E., Jones R.E., et al. Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiology of Aging 2007, 28:213-225.
45. Reed M.N., Liu P., Kotilinek L.A., Ashe K.H. Effect size of reference memory deficits in the Morris water maze in Tg2576 mice. Behavioral Brain Research 2011, 212:115-120.
46. Ribes, D., Torrente, M., Vicens, P., Colomina, M. T., Gómez, M., & Domingo, J. L. (2011). Recognition memory and β-amyloid plaques in adult Tg2576 mice are not modified after oral exposure to aluminum. Alzheimer's Disease and Associated Disorders (Epublished ahead of print).
47. Rustay N.R., Cronin E.A., Curzon P., Markosyan S., Bitner R.S., Ellis T.A., et al. Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer's disease. Brain Research 2010, 1311:136-147.
48. Sarter M., Hasselmo M.E., Bruno J.P., Givens B. Unraveling the attentional functions of cortical cholinergic inputs: Interactions between signal-driven and cognitive modulation of signal detection. Brain Research Reviews 2005, 48:98-111.
49. Selkoe D.J. Genes proteins and therapy. Physiological Reviews 2001, 81:741-766.
50. Selkoe D.J. Alzheimer's disease: Mechanistic understanding predicts novel therapies. Annals of Internal Medicine 2004, 140:627-638.
51. Sherman K., Kuster J.E., Dean R.L., Bartus R.T., Freidman E. Presynaptic cholinergic mechanisms in brain of aged rats with memory impairments. Neurobiology of Aging 1981, 2:99-104.
52. Sidman M. Tactics of scientific research 1960, New York, Basic Books.
53. Stackman R.W., Eckenstein F., Frei B., Kulhanek D., Nowlin J., Quinn J.F. Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment. Experimental Neurology 2003, 184:510-520.
54. Wang R., Dineley K.T., Sweatt J.D., Zheng H. Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis. Neuroscience 2004, 126:305-312.
55. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. Journal of Neuroscience 2002, 22:1858-1867.
56. Wilner P. Behavioral models in psychopharmacology. Behavioral models in psychopharmacology: Theoretical, industrial and clinical perspectives 1991, Cambridge University Press, Cambridge, UK. P. Willner (Ed.).
57. Winters B.D., Dunnett S.B. Selective lesioning of the Cholinergic Septo-Hippocampal Pathway does not disrupt spatial short term memory: A comparison with the effects of Fimbria-Fornix lesions. Behavioral Neuroscience 2004, 118:546-562.
58. Zanetti O., Binetti G., Magni E., Rozzini L., Bianchetti A., Trabucchi M. Procedural memory stimulation in Alzheimer's disease: Impact of a training programme. Acta Neurologica Scandinavica 1997, 95:152-157.
59. Zhang M., Balmadrid C., Kelley A.E. Nucleus accumbens opoid, GABAergic, and dopaminergic modulation of palatable food motivation: Contrasting effects revealed by a progressive ratio study in the rat. Behavioral Neuroscience 2003, 117:202-211.
60. Zhuo J.M., Prescott S.L., Murray M.E., Zhang H.Y., Baxter M.G., Nicolle M.M. Early discrimination reversal learning impairment and preserved spatial learning in a longitudinal study of Tg2576 APPsw mice. Neurobiology of Aging 2007, 28:1248-1257.